Circular RNAs (circRNAs) are endogenous RNAs with a covalently closed single‐stranded
transcript. They are a novel class of genomic regulators that are linked to many important …

Pulmonary hypertension (PH) refers to a clinical and pathophysiological syndrome in which
pulmonary vascular resistance and pulmonary arterial pressure are increased due to …

The quality of life and survival rates of patients with pulmonary arterial hypertension
associated with congenital heart disease (CHD–PAH) have been greatly improved by defect …

Currently, there have been breakthroughs in the study of the underlying mechanisms of
pulmonary arterial hypertension, but treatment is still challenging. The aim of this study was …

Pulmonary arterial hypertension (PAH) is a severe, multifactorial, and frequently
misdiagnosed disorder. The aim of this observational study was to compare the plasma and …

Abstract Objective/Background Proliferation is a widely recognized trigger for pulmonary
hypertension (PH), a life‐threatening, progressive disorder of pulmonary blood vessels. This …

Introduction: Over time and despite optimal medical management of patients with pulmonary
hypertension (PH), the right ventricle (RV) function deteriorates from an adaptive to …

Background Infants with SVHD experience morbidity related to pulmonary vascular
inadequacy. Metabolomic analysis involves a systems biology approach to identifying novel …

Pulmonary hypertension due to left heart disease (PH‐LHD) is regarded as the most
prevalent form of pulmonary hypertension (PH). Indeed, PH is an independent risk factor …

Pulmonary arterial hypertension, or PAH, is a condition that is characterized by pulmonary
artery pressures above 20 mmHg (at rest). In the treatment of PAH, the pulmonary vascular …